Scientific article

S-ICDs : advantages and opportunities for improvement

Published inExpert review of medical devices, vol. 19, no. 3, p. 237-245
Publication date2022-03-17
First online date2022-03-17

Introduction: The subcutaneous implantable cardioverter defibrillator (S-ICD) is currently in its third generation and has been adopted in guidelines and in mainstream clinical practice. Considerable improvements have been made since the introduction of this device over a decade ago.

Areas covered: A literature search was undertaken in Pubmed on articles relating to the S-ICD.

Expert opinion: The therapy has been proven to be safe and effective and is a valuable option in selected patients. Nevertheless, there remain many shortcomings of the S-ICD which are discussed in this review, and which hopefully will be addressed by future generations of the device.

  • CIED
  • S-ICD
  • Subcutaneous implantable cardioverter defibrillator
  • Cardiac implantable electronic device
  • Implantable cardioverter defibrillator
Citation (ISO format)
FRIEDLI, Axel, BURRI, Haran Kumar. S-ICDs : advantages and opportunities for improvement. In: Expert review of medical devices, 2022, vol. 19, n° 3, p. 237–245. doi: 10.1080/17434440.2022.2054335
Main files (1)
Article (Published version)
ISSN of the journal1743-4440

Technical informations

Creation10/19/2023 2:19:58 PM
First validation02/28/2024 3:11:16 PM
Update time02/28/2024 3:11:16 PM
Status update02/28/2024 3:11:16 PM
Last indexation05/06/2024 6:03:01 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack